Advancing GLP-1 Clinical Trials with Quantitative MRI: Multi-Organ and Body Composition Imaging for Deep Phenotyping
Time: 9:30 am - 10:00 am
day: Day Two
Details:
- Beyond weight loss: Using quantitative MRI to track fat distribution and body composition changes in GLP-1 clinical trials
- Multi-organ insights: Leveraging MRI to phenotype metabolic diseases by assessing liver, kidney, heart, and muscle health
- Enhancing trial outcomes: Integrating quantitative MRI with traditional biomarkers for deeper patient insights and optimized clinical trial design
